Effective long-term treatment of pseudohypoparathyroidism with oral 1α-hydroxy- and 1,25-dihydroxycholecalciferol
- 1 August 1976
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 89 (2) , 266-268
- https://doi.org/10.1016/s0022-3476(76)80464-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The control of 25-hydroxyvitamin D metabolism by inorganic phosphorusPublished by Elsevier ,2004
- Treatment of Hypoparathyroidism and Pseudohypoparathyroidism with Metabolites of Vitamin D: Evidence for Impaired Conversion of 25-Hydroxyvitamin D to 1α,25-Dihydroxyvitamin DNew England Journal of Medicine, 1975
- Response to Crystalline 1α-Hydroxyvitamin D3 in Vitamin D DependencyPediatric Research, 1975
- 1,25-Dihydroxyvitamin D3 and 1,α-Hydroxyvitamin D3 in Children: Biologic and Therapeutic Effects in Nutritional Rickets and Different Types of Vitamin D ResistancePediatric Research, 1975
- PseudohypoparathyroidismThe American Journal of Medicine, 1975
- 1,25-DIHYDROXYCHOLECALCIFEROL IN HYPOPARATHYROIDISM AND PSEUDOHYPOPARATHYROIDISMThe Lancet, 1975
- Excessive Thyrotropin Response to Thyrotropin-releasing Hormone in PseudohypoparathyroidismPediatric Research, 1975
- 1,25-DIHYDROXYCHOLECALCIFEROL AND 1α-HYDROXYCHOLECALCIFEROL IN HYPOPARATHYROIDISMThe Lancet, 1974
- Action of 1,25-Dihydroxycholecalciferol, a Potent, Kidney-Produced Metabolite of Vitamin D3, in Uremic ManNew England Journal of Medicine, 1972
- Radioimmunoassay of human parathyroid hormone in serumJournal of Clinical Investigation, 1971